Mangoceuticals (MGRX) Income from Non-Controlling Interests (2023 - 2026)
Mangoceuticals recorded quarterly Income from Non-Controlling Interests of -$1533.0 in Q1 2026, down 878.17% quarter-over-quarter from $197.0 in Q4 2025, and down 1464.29% year-over-year from $112.37 in Q1 2025.
Mangoceuticals' Income from Non-Controlling Interests history runs 4 years deep, the most recent figure standing at -$1533.0 for Q1 2026.
- In Q1 2026, Income from Non-Controlling Interests fell 1464.29% year-over-year to -$1533.0; the TTM figure through Mar 2026 stood at -$1896.0 (down 65.88% YoY), while the FY2025 annual figure was -$461.0, up 57.35% from the prior year.
- Income from Non-Controlling Interests came in at -$1533.0 for Q1 2026 at Mangoceuticals, down from $197.0 in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $197.0 in Q4 2025 to a low of -$1.8 million in Q3 2023.
- A 4-year average of -$180253.5 and a median of -$292.0 in 2024 frame the typical range for Income from Non-Controlling Interests.
- Across the five-year window, Income from Non-Controlling Interests jumped 180.74% in 2025 and sank 1464.29% in 2026, its largest moves.
- Mangoceuticals' Income from Non-Controlling Interests stood at -$1.8 million in 2023, then surged by 99.99% to -$244.0 in 2024, then soared by 180.74% to $197.0 in 2025, then plunged by 878.17% to -$1533.0 in 2026.
- According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered -$1533.0, $197.0, and -$558.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | - |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | -157,000.00 |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | - |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | - |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | - |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 646,000.00 |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | - |
| 10 | Mangoceuticals | 7.03 Mn | 6.84 Mn | 29,001.00 | -1,533.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,533.00 |
| Dec 31, 2025 | 197.00 |
| Sep 30, 2025 | -558.00 |
| Jun 30, 2025 | -2.00 |
| Mar 31, 2025 | -98.00 |
| Dec 31, 2024 | -244.00 |
| Sep 30, 2024 | -461.00 |
| Jun 30, 2024 | -340.00 |
| Mar 31, 2024 | -36.00 |
| Sep 30, 2023 | -1.80 Mn |